Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma.

Publication Year: 2022

DOI:
10.2478/jtim-2022-0022

PMCID:
PMC10732496

PMID:
38130635

Journal Information

Full Title: J Transl Int Med

Abbreviation: J Transl Int Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: None declared."

Evidence found in paper:

"This work was supported by National Natural Science Foundation of China (No. 82022049, Xue J; No. 82073105, Niu N), Shanghai Rising-Star Program (19QA1408300, Niu N), the Science and Technology Commission of Shanghai Municipality (20ZR1432900, Niu N), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (No. 20161312, Xue J), and State Key Laboratory of Oncogenes and Related Genes (KF2113, Niu N)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025